Video

Setting expectations in patients with prostate cancer receiving HIFU

“[Patients]… need to understand what they’re gaining and what they’re giving up,” says Samuel J. Peretsman, MD, in this video.

In this video, the second installment of Urology Times® Editorial Consultant J. Brantley Thrasher, MD,’s recent interview with Samuel J. Peretsman, MD, regarding high-intensity focused ultrasound, Peretsman explains what he tells patients undergoing HIFU to expect postoperatively. Peretsman is with Urology Specialists of the Carolinas in Charlotte, North Carolina, and Thrasher is executive director of the American Board of Urology.

More videos:

HIFU for prostate cancer: How it works, criteria for treatment, and contraindications

Attorney Kenton H. Steele, Esq, on the medico-legal dangers of friendly prescribing

Dr. Kathleen Kieran discusses peer-reviewed authorship for women in urology

Related Videos
Alexander Pastuszak, MD, PhD: Is hormone therapy safe after prostate cancer radiotherapy?
Refining prostate cancer therapy strategy to address RAPTOR findings
Soumyajit Roy, MS, MBBS: The effect of prostate cancer patient history in RAPTOR
1 KOL is featured in this series.
1 KOL is featured in this series.
Nicholas van AS, MD, MBBCH: The case for SBRT as a standard of care for localized prostate cancer
Pierre Blanchard, MD, PhD: What can hydrogel space provide to optimal prostate cancer care?
Savita Dandapani, MD, PhD: Findings from the phase 2 SHARP trial
A panel of 4 experts on prostate cancer
Benjamin Pockros, MD, MBA, answers a question during a Zoom video interview
Related Content
© 2024 MJH Life Sciences

All rights reserved.